IP Library Granted Patent US 10,377,722
Granted Patent B2
US 10,377,722 · App. 15/600,196 · Granted Aug 13, 2019

Rosuvastatin calcium and process for producing intermediate thereof

Inventors: Naoyuki Watanabe (Fukuoka, JP); Tomoko Maeda (Kanagawa, JP); Yasumasa Dekishima (Kanagawa, JP); Hiroshi Kawabata (Kanagawa, JP); Masaki Nagahama (Fukuoka, JP); Kosuke Ito (Shizuoka, JP)
Assignee: API CORPORATION
C07D239/42C12N9/0006C12P17/12C12Y101/01184
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,377,722
App. No.
15/600,196
Granted
Aug 13, 2019
Kind
B2
Abstract

An object of the present invention is to provide a novel method capable of producing rosuvastatin calcium and intermediates therefor efficiently, inexpensively and with high purity. The present invention provides a method of efficiently producing rosuvastatin calcium and intermediates therefor having a high purity at an industrial scale, without using an extremely low temperature reaction or a special asymmetric catalyst.

Claims (13)

1. A production method of a compound represented by the following formula (2):

wherein R is a primary alkyl group having 1-8 carbon atoms or a secondary alkyl group having 3-6 carbon atoms, the method comprising:

(i) reducing a compound represented by the following formula (1a):

wherein R is as defined for R in said formula (2), comprising reacting the compound with an enzyme having an activity capable of stereoselectively reducing a carbonyl group, a microorganism or cell having an ability to produce the enzyme, a treated product of the microorganism or cell, and/or a culture solution containing the enzyme obtained by culturing the microorganism or cell;

wherein said enzyme comprises a polypeptide selected from:

(A) a carbonyl reductase (OCR1) polypeptide of SEQ ID NO: 2 from Ogataea minuta var. nonfermentans NBRC1473,

(B) a polypeptide consisting of an amino acid sequence having a homology of 90% or more to the amino acid sequence shown in SEQ ID NO: 2, and having an activity to convert a compound represented by said formula (1a) to a compound represented by said formula (2), and

(C) a polypeptide comprising an amino acid sequence which is the amino acid sequence shown in SEQ ID NO: 2, wherein 20 or less amino acids are substituted, deleted or added, and having an activity to convert a compound represented by said formula (1a) to a compound represented by said formula (2).

2. The production method according to claim 1 , wherein the gene encoding said enzyme is a DNA comprising the base sequence selected from:

(D) the base sequence shown in SEQ ID NO: 1,

(E) a base sequence that hybridizes to a DNA consisting of a sequence complementary to the base sequence shown in SEQ ID NO: 1 under stringent conditions, and encodes a polypeptide having an activity to convert the compound represented by formula (1a) to the compound represented by formula (2), and

(F) the base sequence shown in SEQ ID NO: 1 wherein 60 or less bases are substituted, deleted or added, and encodes a polypeptide having an activity to convert the compound represented by formula (1a) to the compound represented by formula (2).

3. The production method according to claim 1 , wherein (i) is performed in the presence of a polyhydric alcohol.

Assignments (3)
CHANGE OF ADDRESS Recorded Aug 21, 2025
From: API CORPORATION
To: API CORPORATION
Reel/Frame 072498/0511 →
MERGER Recorded Aug 21, 2025
From: API CORPORATION
To: UBE CORPORATION
Reel/Frame 072554/0211 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2017
From: WATANABE, NAOYUKI; DEKISHIMA, YASUMASA; NAGAHAMA, MASAKI; MAEDA, TOMOKO; OHTANI, TAKASHI; ITO, KOSUKE; KAWABATA, HIROSHI
To: API CORPORATION
Reel/Frame 042903/0591 →
Priority Claims (3)
JP 2014-021769 · Feb 6, 2014 · national
JP 2014-209142 · Oct 10, 2014 · national
JP 2014-209480 · Oct 10, 2014 · national
Continuity (2)
Division 15116861
Related Publication 20170305867A1 · Oct 26, 2017